PureTech Health (PTCHF) Expected to Post Quarterly Earnings on Tuesday
by Teresa Graham · The Cerbat GemPureTech Health (OTCMKTS:PTCHF – Get Free Report) is expected to be announcing its resultson Tuesday, September 22nd. Analysts expect PureTech Health to announce earnings of ($0.1160) per share and revenue of $24.80 million for the quarter.
PureTech Health Stock Performance
Shares of PureTech Health stock opened at $1.65 on Friday. PureTech Health has a twelve month low of $1.53 and a twelve month high of $1.92. The business’s fifty day moving average price is $1.58 and its 200 day moving average price is $1.65.
About PureTech Health
PureTech Health PLC (“PureTech”) is a clinical-stage biopharmaceutical company focused on the development of innovative medicines to address serious diseases with high unmet medical need. Founded in 2005 by Daphne Zohar and headquartered in Boston, Massachusetts with operations in both North America and Europe, PureTech applies its proprietary platforms to advance therapeutic candidates across immunology, neuroscience and lymphatic-focused indications.
The company leverages three core technology platforms—immune tolerance, gut-targeted delivery and lymphatic transport—to develop novel molecules designed for enhanced specificity and durability of effect.
Further Reading
- Five stocks we like better than PureTech Health
- Lennar’s Earnings Miss May Be Sending a Bigger Warning About U.S. Housing
- Priced for a Pullback or More Gains? These 3 Stocks Are Testing the Limits
- These 3 Agentic AI Stocks Have More Than Hype Behind Their Growth Stories
- Not Just Banks: 3 Trading Stocks to Watch After the Fed Rate Hike